Search Results - eli+yazigi

1 Results Sort By:
Immune Cell Modulation using Phosphodiesterase Activating Drug
Value PropositionAdjuvant to support the widespread use of immunotherapy in cancer.May improve the responses to checkpoint inhibitors (Keytruda) or CAR T cell activity.Diverse applications as a supplement to various precision cancer therapies.Repurposes a commercially available chemical compound for cancer treatment.Scalable synthesis, given the existing...
Published: 1/22/2026   |   Inventor(s): Christopher Jackson, Landon Hansen, Eli Yazigi, Henry Brem
Keywords(s):  
Category(s): Clinical and Disease Specializations > Immunology, Clinical and Disease Specializations > Immuno-Oncology, Clinical and Disease Specializations > Oncology > Brain Cancer, Clinical and Disease Specializations > Oncology
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum